ELI LILLY AND COMPANY Increase (Decrease) in Other Operating Assets and Liabilities, Net
ELI LILLY AND COMPANY (LLY) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of $2.33 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2026-08-05
- ELI LILLY AND COMPANY increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-06-30 was $670.00M, a 70.39% decline year-over-year.
- ELI LILLY AND COMPANY increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-03-31 was $1.66B, a 50.54% decline year-over-year.
- ELI LILLY AND COMPANY increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-09-30 was -$1.21B, a 12427.55% decline year-over-year.
- ELI LILLY AND COMPANY increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-06-30 was $2.26B, a 61.75% increase year-over-year.
- ELI LILLY AND COMPANY increase (decrease) in other operating assets and liabilities, net for fiscal 2009 was -$956.90M, a 203.54% decline from fiscal 2008.
- ELI LILLY AND COMPANY increase (decrease) in other operating assets and liabilities, net for fiscal 2008 was $924.20M.
- ELI LILLY AND COMPANY increase (decrease) in other operating assets and liabilities, net for fiscal 2007 was -$53.80M.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $670.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.33B 10-Q · filed 2026-08-05 | |||||
| 2026-03-31 | $1.66B 10-Q · filed 2026-04-30 | ||||||
| 2025-09-30 | -$1.21B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $1.05B derived: sum of 2 quarters · filed 2026-08-05 | $4.42B 10-Q · filed 2025-10-30 | ||||
| 2025-06-30 | $2.26B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.63B 10-Q · filed 2026-08-05 | $5.63B 10-Q · filed 2025-08-07 | ||||
| 2025-03-31 | $3.36B 10-Q · filed 2026-04-30 | $3.36B 10-Q · filed 2025-05-01 | |||||
| 2024-09-30 | $9.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $1.41B derived: sum of 2 quarters · filed 2025-10-30 | $3.16B 10-Q · filed 2025-10-30 | ||||
| 2024-06-30 | $1.40B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $3.15B 10-Q · filed 2025-08-07 | |||||
| 2024-03-31 | $1.75B 10-Q · filed 2025-05-01 | ||||||
| 2023-09-30 | -$793.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $46.90M derived: sum of 2 quarters · filed 2024-10-30 | -$117.20M 10-Q · filed 2024-10-30 | ||||
| 2023-06-30 | $840.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $676.10M 10-Q · filed 2024-08-08 | |||||
| 2023-03-31 | -$164.10M 10-Q · filed 2024-04-30 | ||||||
| 2022-09-30 | -$927.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$857.70M derived: sum of 2 quarters · filed 2023-11-02 | -$823.40M 10-Q · filed 2023-11-02 | -$821.50M 10-Q · filed 2022-11-01 | |||
| 2022-06-30 | $69.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $104.20M 10-Q · filed 2023-08-08 | $117.60M 10-Q · filed 2022-08-04 | ||||
| 2022-03-31 | $34.30M 10-Q · filed 2023-04-27 | $45.50M 10-Q · filed 2022-04-29 | |||||
| 2021-09-30 | $666.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $445.30M derived: sum of 2 quarters · filed 2022-11-01 | $548.10M 10-Q · filed 2022-11-01 | ||||
| 2021-06-30 | -$221.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$118.40M 10-Q · filed 2022-08-04 | |||||
| 2021-03-31 | $102.80M 10-Q · filed 2022-04-29 | ||||||
| 2020-09-30 | -$249.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | -$1.18B derived: sum of 2 quarters · filed 2021-10-27 | $232.20M 10-Q · filed 2021-10-27 | ||||
| 2020-06-30 | -$926.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $481.60M 10-Q · filed 2021-08-03 | |||||
| 2020-03-31 | $1.41B 10-Q · filed 2021-04-30 | ||||||
| 2019-09-30 | $247.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $1.05B derived: sum of 2 quarters · filed 2020-10-28 | $1.76B 10-Q · filed 2020-10-28 | ||||
| 2019-06-30 | $802.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $1.52B 10-Q · filed 2020-07-31 | |||||
| 2019-03-31 | $714.30M 10-Q · filed 2020-05-01 | ||||||
| 2018-09-30 | -$293.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $368.20M derived: sum of 2 quarters · filed 2019-10-25 | $1.64B 10-Q · filed 2019-10-25 | ||||
| 2018-06-30 | $662.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $1.93B 10-Q · filed 2019-08-02 | |||||
| 2018-03-31 | $1.27B 10-Q · filed 2019-05-02 | ||||||
| 2017-09-30 | -$593.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$469.80M derived: sum of 2 quarters · filed 2018-11-06 | $525.20M 10-Q · filed 2018-11-06 | ||||
| 2017-06-30 | $123.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25 | $1.12B 10-Q · filed 2018-07-25 | -$1.12B 10-Q · filed 2017-07-28 | ||||
| 2017-03-31 | $995.00M 10-Q · filed 2018-04-27 | -$995.00M 10-Q · filed 2017-05-01 | |||||
| 2016-09-30 | $2.41B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $2.49B derived: sum of 2 quarters · filed 2017-10-27 | $1.11B 10-Q · filed 2017-10-27 | -$1.22B 10-Q · filed 2016-10-28 | |||
| 2016-06-30 | $86.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | -$1.30B 10-Q · filed 2017-07-28 | -$1.40B 10-Q · filed 2016-07-28 | ||||
| 2016-03-31 | -$1.38B 10-Q · filed 2017-05-01 | -$1.43B 10-Q · filed 2016-04-29 | |||||
| 2015-09-30 | -$75.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | -$49.90M derived: sum of 2 quarters · filed 2016-10-28 | -$963.60M 10-Q · filed 2016-10-28 | -$660.10M 10-Q · filed 2015-10-30 | |||
| 2015-06-30 | $25.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | -$887.80M 10-Q · filed 2016-07-28 | -$686.30M 10-Q · filed 2015-07-30 | ||||
| 2015-03-31 | -$913.70M 10-Q · filed 2016-04-29 | ||||||
| 2014-09-30 | $473.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $369.50M derived: sum of 2 quarters · filed 2015-10-30 | -$548.30M 10-Q · filed 2015-10-30 | ||||
| 2014-06-30 | -$103.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$1.02B 10-Q · filed 2015-07-30 | |||||
| 2014-03-31 | -$917.80M 10-Q · filed 2015-04-30 | -$941.30M 10-Q · filed 2014-04-28 | |||||
| 2013-09-30 | -$226.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | -$450.20M derived: sum of 2 quarters · filed 2014-10-29 | -$1.50B 10-Q · filed 2014-10-29 | ||||
| 2013-06-30 | -$223.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-28 | -$1.27B 10-Q · filed 2014-07-28 | |||||
| 2013-03-31 | -$1.05B 10-Q · filed 2014-04-28 | $1.05B 10-Q · filed 2013-04-26 | |||||
| 2012-09-30 | $488.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$970.20M derived: sum of 2 quarters · filed 2013-10-30 | -$271.50M 10-Q · filed 2013-10-30 | $271.50M 10-Q · filed 2012-10-26 | |||
| 2012-06-30 | -$1.46B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26 | -$759.80M 10-Q · filed 2013-07-26 | $759.80M 10-Q · filed 2012-07-27 | ||||
| 2012-03-31 | $698.70M 10-Q · filed 2013-04-26 | ||||||
| 2011-09-30 | -$166.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-26 | -$672.30M derived: sum of 2 quarters · filed 2012-10-26 | -$76.70M 10-Q · filed 2012-10-26 | $76.70M 10-Q · filed 2011-10-28 | |||
| 2011-06-30 | -$506.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | $89.40M 10-Q · filed 2012-07-27 | -$89.40M 10-Q · filed 2011-07-29 | ||||
| 2011-03-31 | $595.60M 10-Q · filed 2012-04-30 | -$595.60M 10-Q · filed 2011-04-29 | |||||
| 2010-09-30 | -$116.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | -$5.20M derived: sum of 2 quarters · filed 2011-10-28 | -$820.30M 10-Q · filed 2011-10-28 | -$9.20M derived: sum of 4 quarters · filed 2011-10-28 | |||
| 2010-06-30 | $111.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-29 | -$703.50M 10-Q · filed 2011-07-29 | $107.60M derived: sum of 3 quarters · filed 2011-07-29 | -$465.50M derived: sum of 4 quarters · filed 2011-07-29 | |||
| 2010-03-31 | -$815.10M 10-Q · filed 2011-04-29 | -$4.00M derived: sum of 2 quarters · filed 2011-04-29 | -$577.10M derived: sum of 3 quarters · filed 2011-04-29 | -$1.10B derived: sum of 4 quarters · filed 2011-04-29 | |||
| 2009-12-31 | $811.10M derived: 10-K 12 month − 10-Q 9 month · filed 2010-02-22 | $238.00M derived: sum of 2 quarters · filed 2010-10-29 | -$284.90M derived: sum of 3 quarters · filed 2010-10-29 | -$956.90M 10-K · filed 2010-02-22 | |||
| 2009-09-30 | -$573.10M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-10-29 | -$1.10B derived: sum of 2 quarters · filed 2010-10-29 | -$1.77B 10-Q · filed 2010-10-29 | -$987.80M derived: sum of 4 quarters · filed 2010-10-29 | |||
| 2009-06-30 | -$522.90M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2010-08-02 | -$1.19B 10-Q/A · filed 2010-08-02 | -$414.70M derived: sum of 3 quarters · filed 2010-08-02 | -$219.40M derived: sum of 4 quarters · filed 2010-08-02 | |||
| 2009-03-31 | -$672.00M 10-Q · filed 2010-07-30 | $108.20M derived: sum of 2 quarters · filed 2010-07-30 | $303.50M derived: sum of 3 quarters · filed 2010-07-30 | ||||
| 2008-12-31 | $780.20M derived: 10-K 12 month − 10-Q 9 month · filed 2010-02-22 | $975.50M derived: sum of 2 quarters · filed 2010-02-22 | $924.20M 10-K · filed 2010-02-22 | ||||
| 2008-09-30 | $195.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-30 | $144.00M 10-Q · filed 2009-10-30 | |||||
| 2008-06-30 | -$51.30M 10-Q · filed 2009-07-31 | ||||||
| 2007-12-31 | -$53.80M 10-K · filed 2010-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |